BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31317804)

  • 1. Bergamottin can be used to assess CYP3A-mediated intestinal first-pass metabolism without affecting P-glycoprotein-mediated efflux in rats.
    Suzuki K; Taniyama K; Aoyama T; Watanabe Y
    Xenobiotica; 2020 Apr; 50(4):401-407. PubMed ID: 31317804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats.
    Suzuki K; Taniyama K; Aoyama T; Watanabe Y
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):385-392. PubMed ID: 32078103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D
    Maeng HJ; Doan TNK; Yoon IS
    Drug Dev Res; 2019 May; 80(3):333-342. PubMed ID: 30537097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Effects of Maytenus ilicifolia on the Activities of Cytochrome P450 3A and P-glycoprotein.
    do Nascimento SB; de Lima Nascimento M; de Araújo LL; de Oliveira FM; do Carmo Vieira M; Duarte-Almeida JM; Siqueira JM; da Costa César I; Derendorf H; de Castro WV
    Curr Drug Metab; 2020; 21(4):281-290. PubMed ID: 32394829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: II. Ritonavir effects on CYP3A and P-glycoprotein activities.
    Kharasch ED; Bedynek PS; Walker A; Whittington D; Hoffer C
    Clin Pharmacol Ther; 2008 Oct; 84(4):506-12. PubMed ID: 19238656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P-glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats.
    Zhang J; Xie Q; Kong W; Wang Z; Wang S; Zhao K; Chen Y; Liu X; Liu L
    J Pharm Pharmacol; 2020 Mar; 72(3):448-460. PubMed ID: 31863502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters.
    Wang Z; Yang H; Xu J; Zhao K; Chen Y; Liang L; Li P; Chen N; Geng D; Zhang X; Liu X; Liu L
    Drug Metab Dispos; 2019 Oct; 47(10):1066-1079. PubMed ID: 31399507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
    Eagling VA; Profit L; Back DJ
    Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Evaluation of the Complex Drug-Drug Interactions of Maraviroc: Contribution of Cytochrome P450 3A, P-Glycoprotein and Organic Anion Transporting Polypeptide 1B1.
    Kimoto E; Vourvahis M; Scialis RJ; Eng H; Rodrigues AD; Varma MVS
    Drug Metab Dispos; 2019 May; 47(5):493-503. PubMed ID: 30862625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influences of aconitine, an active/toxic alkaloid from aconitum, on the oral pharmacokinetics of CYP3A probe drug buspirone in rats.
    Zhu L; Lu L; Guo E; Wu J; Wang Y; Hu M; Liu Z
    Drug Metab Lett; 2014; 8(2):135-44. PubMed ID: 25434398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of intestinal absorption of bicyclol in rats: active efflux transport and metabolism as causes of its poor bioavailability.
    Tan W; Chen H; Zhao J; Hu J; Li Y
    J Pharm Pharm Sci; 2008; 11(3):97-105. PubMed ID: 18801310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of pharmacokinetic enhancement between ritonavir and saquinavir; micro/small dosing tests using midazolam (CYP3A4), fexofenadine (p-glycoprotein), and pravastatin (OATP1B1) as probe drugs.
    Ieiri I; Tsunemitsu S; Maeda K; Ando Y; Izumi N; Kimura M; Yamane N; Okuzono T; Morishita M; Kotani N; Kanda E; Deguchi M; Matsuguma K; Matsuki S; Hirota T; Irie S; Kusuhara H; Sugiyama Y
    J Clin Pharmacol; 2013 Jun; 53(6):654-61. PubMed ID: 23381882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP3A but not P-gp plays a relevant role in the in vivo intestinal and hepatic clearance of the delta-specific phosphoinositide-3 kinase inhibitor leniolisib.
    De Buck S; Kucher K; Hara H; Gray C; Woessner R
    Biopharm Drug Dispos; 2018 Sep; 39(8):394-402. PubMed ID: 30171694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys.
    Ogasawara A; Kume T; Kazama E
    Drug Metab Dispos; 2007 Mar; 35(3):410-8. PubMed ID: 17142564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal first-pass metabolism by cytochrome p450 and not p-glycoprotein is the major barrier to amprenavir absorption.
    Dufek MB; Bridges AS; Thakker DR
    Drug Metab Dispos; 2013 Sep; 41(9):1695-702. PubMed ID: 23821186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of novobiocin as a selective inhibitor of intestinal breast cancer resistance protein (Bcrp) in rats.
    Suzuki K; Taniyama K; Aoyama T; Watanabe Y
    Xenobiotica; 2020 Sep; 50(9):1121-1127. PubMed ID: 31868552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sinapic acid on hepatic cytochrome P450 3A2, 2C11, and intestinal P-glycoprotein on the pharmacokinetics of oral carbamazepine in rats: Potential food/herb-drug interaction.
    Raish M; Ahmad A; Ansari MA; Alkharfy KM; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
    Epilepsy Res; 2019 Jul; 153():14-18. PubMed ID: 30927680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Cytochrome P450 Activity by 18β-Glycyrrhetic Acid and its Consequence on Buspirone Pharmacokinetics in Rats.
    Kim SB; Cho HJ; Kim YS; Kim DD; Yoon IS
    Phytother Res; 2015 Aug; 29(8):1188-94. PubMed ID: 26010440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.